Insulin pump therapy in children with type 1 diabetes;Inzulinske pumpe u liječenju djece sa šećernom bolešću

Paediatria Croatica, Supplement

Volumn 47, Issue 1, 2003, Pages 163-166

  Dumić, Miroslav ^a   Špehar, Anita ^b   Janjanin, Nevena ^a  

^a KBC Zagreb   (Croatia)

^b NONE

Author keywords

Insulin pump; Type 1 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

BIOTECHNOLOGY; CONFERENCE PAPER; CONTINUOUS INFUSION; DRUG MANUFACTURE; DRUG USE; FAMILY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN PUMP; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SELECTION; PHYSIOLOGY; QUALITY CONTROL; QUALITY OF LIFE;

EID: 42149100735     PISSN: 1330724X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Plotnick L, Clark L. Insulin Pumps in Children and Adolescents. Endocrinologist 2001; 11: 112-7.
2. Bode BW, Strange P. Efficacy, Safety, and Pump Compatibility of Insulin Aspart Used in Continuous Subcutaneous Insulin Infusion Therapy in Patients With Type 1 Diabetes. Diabetes Care 2001; 24: 69-72.
3. Comparison of Insulin Aspart With Buffered Regular Insulin and Insulin Lispro in Continuous Subcutaneous Insulin Infusion. Diabetes Care 2002; 25: 439-44.
4. Renard E, Costalat G, Bringer J. From external to implantable insulin pump, can we close the loop? Diabetes Metab 2002; 28 (4 Pt 2): 19-25.
5. DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care 2002; 25: 2074-80.
6. Litton J, Rice A, Friedman N, Oden J, Lee MM, Freemark M. Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. J Pediatr 2002; 141: 490-5.
7. Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 2002; 324: 705.
8. Saha ME, Huuppone T, Mikael K, Juuti M, Komulainen J. Continuous subcutaneous insulin infusion in the treatment of children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2002; 15: 1005-10.
9. Raile K, Noelle V, Landgraf R, Schwarz HP. Weight in adolescents with type 1 diabetes mellitus during continuous subcutaneous insulin infusion (CSII) therapy. J Pediatr Endocrinol Metab 2002; 15: 607-12.
10. Hanas R. Selection for and initiation of continuous subcutaneous insulin infusion. Proceedings from a workshop. Horm Res 2002; 57 (Suppl 1): 101-4.
11. Bode BW, Sabbah HT, Gross TM, Fredrickson LP, Davidson PC. Diabetes management in the new millennium using insulin pump therapy. Diabetes Metab Res Rev 2002; 18 (Suppl 1): 14-20.
12. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002; 25: 593-8.
13. Lenhard MJ, Reeves GD. Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med 2001; 161: 2293-300.
14. Lauritzen T, Pramming S, Deckert T, Binder C. Pharmacokinetics of continuous subcutaneous insulin infusion. Diabetologia 1983; 24: 326-9.